Filed in

Raise Your Awareness About ACS Colorectal Cancer Research

March is Colorectal Cancer Awareness Month. See how American Cancer Society researchers are helping put an end to this disease.

Published on: March 5, 2024

American Cancer Society (ACS) researchers study the most effective ways to help people lower their risk of developing colorectal cancer and be motivated to get screened. They also investigate new treatments and ways to live a good life after a colorectal cancer diagnosis. 

We currently have $64 million invested in colorectal cancer research. Take a look at some of the most recently published studies. 

Can Ozempic & Mounjaro Reduce the Risk of Colorectal Cancer?

Early study finds GLP-1 medicines reduce the risk of colorectal cancer more than other diabetes medicines, especially for people with overweight/obesity.

New Spatial Maps of the Intestine Show Cell-Level Details

ACS grantee contributed his cellular spatial map of the large and small intestine to a larger project, the Human BioMolecular Atlas Program (HuBMAP).

People Ages 45-49 Are Not Getting Screened for Colorectal Cancer

ACS researchers found that colorectal cancer screening in newly eligible adults is low, with stool tests especially low despite increases during COVID-19.

3 out of 4 People Late for Screening Say Doctor Didn't Suggest It

Researchers found that only 26% of people who were overdue for colorectal cancer screening said their doctor recommended screening in the past year.

See more examples of ACS colorectal cancer research.